| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |